UC

Udayan Cheruvathur Christopher

Active Director Managing Director DIN 11661970
DIN 11661970 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Udayan Cheruvathur Christopher

Data last updated:

Udayan Cheruvathur Christopher is a Managing Director at Pathodoc Diagnostics Private Limited (since 2026).

DIN 11661970
Primary Designation Managing Director
First Appointment 13 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pathodoc Diagnostics Private Limited U86905KL2026PTC102493
Managing Director13 Apr 20262026Active

Board colleagues of Udayan Cheruvathur Christopher

Directorship timeline

Open interactive timeline →
Pathodoc Diagnostics Private Limited
Premium access

Shareholding and investment profile for Udayan Cheruvathur Christopher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udayan Cheruvathur Christopher

Udayan Cheruvathur Christopher currently holds 1 directorship: Pathodoc Diagnostics Private Limited (Managing Director, since 13 Apr 2026).

Udayan Cheruvathur Christopher was first appointed on 13 Apr 2026 as Managing Director at Pathodoc Diagnostics Private Limited.

The current boards of Udayan Cheruvathur Christopher's companies include Cheruvathuriype Udayan (Pathodoc Diagnostics Private Limited), Esther Mani (Pathodoc Diagnostics Private Limited), Neena Issac (Pathodoc Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available